IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.65% | 17.03% | 15.69% | 13.84% | 10.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.65% | 17.03% | 15.69% | 13.84% | 10.87% |
| Cost of Revenue | 10.65% | 22.30% | 13.87% | 13.65% | 10.87% |
| Gross Profit | 13.28% | 15.38% | 16.22% | 13.89% | 10.87% |
| SG&A Expenses | -1.89% | 8.73% | 15.76% | 9.33% | 12.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.71% | 14.79% | 14.61% | 10.73% | 9.57% |
| Operating Income | 33.23% | 22.30% | 18.05% | 20.63% | 14.40% |
| Income Before Tax | 30.68% | 22.80% | 13.70% | 16.87% | 13.38% |
| Income Tax Expenses | 55.09% | 12.65% | 25.74% | 13.55% | 13.64% |
| Earnings from Continuing Operations | 24.13% | 25.17% | 10.44% | 17.81% | 13.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.13% | 25.17% | 10.44% | 17.81% | 13.31% |
| EBIT | 33.23% | 22.30% | 18.05% | 20.63% | 14.40% |
| EBITDA | 36.72% | 24.66% | 20.56% | 20.07% | 13.10% |
| EPS Basic | 23.47% | 24.62% | 10.01% | 17.34% | 12.83% |
| Normalized Basic EPS | 30.01% | 19.02% | 13.27% | 16.39% | 12.91% |
| EPS Diluted | 22.08% | 24.76% | 7.90% | 18.42% | 15.19% |
| Normalized Diluted EPS | 30.24% | 18.92% | 13.00% | 16.18% | 12.72% |
| Average Basic Shares Outstanding | 0.54% | 0.43% | 0.40% | 0.40% | 0.41% |
| Average Diluted Shares Outstanding | 0.34% | 0.50% | 0.64% | 0.61% | 0.60% |
| Dividend Per Share | 17.65% | 17.65% | 13.33% | 13.33% | -- |
| Payout Ratio | -0.05% | 2.60% | 0.03% | -0.03% | -0.76% |